These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2627635)

  • 21. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor.
    Herr HW
    Semin Urol Oncol; 1997 Aug; 15(3):142-6. PubMed ID: 9394908
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience.
    Pansadoro V; Emiliozzi P; de Paula F; Scarpone P; Pansadoro A; Sternberg CN
    Urology; 2002 Feb; 59(2):227-31. PubMed ID: 11834391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment.
    Androulakakis PA; Schneider HM; Jacobi GH; Hohenfellner R
    Br J Urol; 1986 Apr; 58(2):153-6. PubMed ID: 3697629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Consideration of therapeutic choice for grade 3 superficial bladder cancer].
    Noguchi S; Kubota Y; Takase K; Masuda M; Yao M; Hosaka M; Miura T; Kondoh I; Kawasaki C; Moriyama M
    Hinyokika Kiyo; 1996 Sep; 42(9):635-8. PubMed ID: 8918660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer.
    Kakizoe T; Matsumoto K; Nishio Y; Kishi K
    J Urol; 1984 Mar; 131(3):467-72. PubMed ID: 6699986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; von der Maase H
    Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choriocarcinoma and transitional cell carcinoma of the bladder--a case report and review of the clinical evolution of disease in reported cases.
    Abratt RP; Temple-Camp CR; Pontin AR
    Eur J Surg Oncol; 1989 Apr; 15(2):149-53. PubMed ID: 2649396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder.
    Harland SJ; Kynaston H; Grigor K; Wallace DM; Beacock C; Kockelbergh R; Clawson S; Barlow T; Parmar MK; Griffiths GO;
    J Urol; 2007 Sep; 178(3 Pt 1):807-13; discussion 813. PubMed ID: 17631326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Superficial carcinoma of the bladder. The pT1 G3 tumor: progression, recurrence, and survival. Treatment].
    Nogueira March JL; Ojea Calvo A; Castro Iglesias AM; Rodríguez Iglesias B
    Actas Urol Esp; 1992 Oct; 16(9):682-90. PubMed ID: 1488920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.
    Duncan W; Quilty PM
    Radiother Oncol; 1986 Dec; 7(4):299-310. PubMed ID: 3101140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy.
    Quilty PM; Kerr GR; Duncan W
    Radiother Oncol; 1986 Dec; 7(4):311-21. PubMed ID: 3101141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of endoscopic treatment after radical radiotherapy for invasive bladder cancer.
    Smith G; Quilty PM; Duncan W; Chisholm GD; Newsam JE; Hargreave TB
    Br J Urol; 1985 Dec; 57(6):694-9. PubMed ID: 4084728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder.
    Martin JE; Jenkins BJ; Zuk RJ; Oliver RT; Baithun SI
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(3):273-7. PubMed ID: 2494806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Split-course radiotherapy for urinary bladder cancer.
    Salminen E
    Radiother Oncol; 1989 Aug; 15(4):327-31. PubMed ID: 2508191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.